|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Pediatrics (Drs. Christodoulou, Good, and Cawkwell), Division of Allergy/Immunology, University of South Florida/All Children's Hospital, St. Petersburg, FL; Department of Pediatrics (Drs. Emmanuel and Ray); and Department of Pediatrics, Division of Pulmonary Medicine (Dr. Schnapf), University of South Florida, Tampa, FL.
Correspondence to: Christodoulos S. Christodoulou, MD, All Children's Hospital, 801 Sixth St S, Box 9350, St. Petersburg, FL 33701
Minocycline, a semisynthetic tetracycline, is often used to treat acne and rheumatoid arthritis. It has been considered an unlikely drug to be associated with systemic lupus erythematosus; however, many cases of drug-induced lupus related to minocycline have been reported. Some of those reports included pulmonary lupus, but none of the patients described developed respiratory distress. We describe a patient treated with minocycline for 2 years who presented with progressive dyspnea, severe hypoxia, and pulmonary infiltrates necessitating hospitalization and oxygen supplementation.
Key Words: drug-induced SLE minocycline pulmonary lupus respiratory distress
This article has been cited by other articles:
![]() |
M. Oddo, L. Liaudet, M. Lepori, A. F. Broccard, and M.-D. Schaller Relapsing Acute Respiratory Failure Induced by Minocycline Chest, June 1, 2003; 123(6): 2146 - 2148. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Corona Minocycline in Acne Is Still an Issue Arch Dermatol, September 1, 2000; 136(9): 1143 - 1145. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |